Atlant Clinical CRO obtained ISO 9001:2015 certification

| By | Clinical Trials, ISO 9001:2015
0
89

Atlant Clinical, an international CRO, received ISO 9001:2015 certification in Organization and Management of Clinical Trials. The company is the first and only CRO in Russia to be granted the ISO 9001:2015 Certification successfully passing the stringent Bureau Veritas audit.

Atlant Clinical was the first contract research organization in the CIS to receive ISO 9001:2008 issued by Bureau Veritas in 2015. As the company continues its path towards excellence and keeps on the edge of the latest trends in the industry, it was an easy decision to implement the new ISO standards in its processes as soon as possible.

Polly Kim, Quality Assurance and Training Director of Atlant Clinical, said:

“We pride ourselves on quality across all aspects of our operations. We aim to provide our clients with the best services in the market. Each of our employees from the CEO to our Project Administrators are responsible for quality and follow the ISO 9001:2015 standards.”

Bureau Veritas S. A. (formerly BVQI, Bureau Veritas Quality International) is an international certification agency. In addition to certifications, they provide HSE expertise (Health, Safety and Environmental). Today the headquarters are in Neuilly-sur-Seine, nearby La Défense. The company went public on the Paris Bourse in October 2007.

Atlant Clinical, established in 2007, offers a full range of clinical trial and relevant support services throughout the Europe, Russia, Middle East and US. Atlant Clinical has extensive clinical experience (Phases I–IV) in over 15 therapeutic areas. Atlant Clinical’s team consists of more than 150 experienced employees worldwide. Atlant Clinical has offices in the US, Germany, UK, Russia, Lithuania, and Ukraine. The company’s clients range from some of the world’s leading pharmaceutical companies to small and mid-size biotech firms.

SOURCE: atlant clinical
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.